Cart
sales@molnova.com
STS-E412
CAS No. 1609980-39-3
STS-E412( —— )
Catalog No. M34036 CAS No. 1609980-39-3
STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 145 | In Stock |
|
| 2MG | 79 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 211 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTS-E412
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.
-
DescriptionSTS-E412 is a selective activator of tissue-protective EPO receptor (including EPOR and CD131). STS-E412 can be used for research of neurodegenerative diseases and organ protection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1609980-39-3
-
Formula Weight318.76
-
Molecular FormulaC15H15ClN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (156.86 mM; Ultrasonic )
-
SMILESCc1cc(C)n2nc(OCCOc3ccc(Cl)cc3)nc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Miller JL, et al. Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor. Mol Pharmacol. 2015 Aug;88(2):357-67.?
molnova catalog
related products
-
Glutaminase-IN-3
Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.
-
Puerarin-4-O-β-D-glu...
Puerarin-4'-O-β-D-glucopyranoside is a natural product isolated from Pueraria lobata root having estrogenic activity and anti-proliferation in MCF-7 human breast carcinoma cells.
-
Donanemab
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (Aβ) epitope at the N-terminus, showing potential for early Alzheimer's disease research .
